The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 71 results:
Author Title Type [ Year(Asc)]
Filters: Author is Triantafyllou, Areti  [Clear All Filters]
2014
Triantafyllou, A., Anyfanti P., Gavriilaki E., Zabulis X., Gkaliagkousi E., Petidis K., et al. (2014).  Association between retinal vessel caliber and arterial stiffness in a population comprised of normotensive to early-stage hypertensive individuals.. Am J Hypertens. 27(12), 1472-8.
Gkaliagkousi, E., Gavriilaki E., Yiannaki E., Markala D., Papadopoulos N., Triantafyllou A., et al. (2014).  Platelet activation in essential hypertension during exercise: pre- and post-treatment changes with an angiotensin II receptor blocker.. Am J Hypertens. 27(4), 571-8.
Triantafyllou, A., Anyfanti P., & Douma S. (2014).  Retinal arteriolar diameters and incident hypertension in initially normotensive individuals: a masked hypertension effect?. J Hypertens. 32(8), 1717.
2013
Triantafyllou, A., Doumas M., Anyfanti P., Gkaliagkousi E., Zabulis X., Petidis K., et al. (2013).  Divergent retinal vascular abnormalities in normotensive persons and patients with never-treated, masked, white coat hypertension.. Am J Hypertens. 26(3), 318-25.
Triantafyllou, A., Pyrpasopoulou A., Anyfanti P., Balaska E., Aslanidis S., & Douma S. (2013).  eLetter: Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors by M Genovese.. Ann Rheum Dis. 72(5), e7.
Anyfanti, P., Triantafyllou A., Petidis K., & Douma S. (2013).  Investigating the association between creatine kinase and failure of antihypertensive treatment: much to be thought of in the everyday clinical setting.. J Hypertens. 31(9), 1914-5.
2012
Pyrpasopoulou, A., Balaska E., Triantafyllou A., Anyfanti P., Aslanidis S., & Douma S. (2012).  B-cell activating factor levels in rheumatoid arthritis patients in response to treatment with biologics.. J Interferon Cytokine Res. 32(7), 338-40.
Gkaliagkousi, E., Doumas M., Gavriilaki E., Triantafyllou A., Vogiatzis K., Anyfanti P., et al. (2012).  Elevated levels of MMP-9 in untreated patients with stage I essential hypertension.. Clin Exp Hypertens. 34(8), 561-6.
Douma, S., Kamparoudis A., Petidis K., Anyfanti P., Doumas M., Gkaliagkousi E., et al. (2012).  Leiomyosarcoma of renal vein, initially resembling pheochromocytoma.. Clin Exp Hypertens. 34(6), 429-31.
Triantafyllou, A., Anyfanti P., & Doumas M. (2012).  Letter by Triantafyllou et al regarding article, "Mild retinopathy is a risk factor for cardiovascular mortality in Japanese with and without hypertension: the Ibaraki Prefectural Health Study".. Circulation. 126(1), e12; author reply e14.
Doumas, M., Anyfanti P., & Triantafyllou A. (2012).  Management of erectile dysfunction: do not forget hypertension.. Arch Intern Med. 172(7), 597-8; discussion 598.
Triantafyllou, A., Gavriilaki E., & Douma S. (2012).  Retinopathy assessment in hypertension is still puzzling.. Am J Hypertens. 25(7), 726.
Douma, S., Petidis K., Kamparoudis A., Gkaliagkousi E., Anyfanti P., Doumas M., et al. (2012).  Surgical management of primary aldosteronism. not everything that shines is gold.. Clin Exp Hypertens. 34(1), 53-6.
2011
Pyrpasopoulou, A., Triantafyllou A., Anyfanti P., Douma S., & Aslanidis S. (2011).  Capillaroscopy as a screening test for clinical antiphospholipid syndrome.. Eur J Intern Med. 22(6), e158-9.
Pyrpasopoulou, A., Douma S., Vassiliadis T., Chatzimichailidou S., Triantafyllou A., & Aslanidis S. (2011).  Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis.. Rheumatol Int. 31(3), 403-4.
2010
Triantafyllou, A., Douma S., Petidis K., Doumas M., Panagopoulou E., Pyrpasopoulou A., et al. (2010).  Prevalence, awareness, treatment and control of hypertension in an elderly population in Greece.. Rural Remote Health. 10(2), 1225.
Pyrpasopoulou, A., Douma S., Triantafyllou A., Simoulidou E., Samara M., Parapanisiou E., et al. (2010).  Response to rituximab and timeframe to relapse in rheumatoid arthritis patients: association with B-cell markers.. Mol Diagn Ther. 14(1), 43-8.
Aslanidis, S., Pyrpasopoulou A., Triantafyllou A., Anyfanti P., Zamboulis C., & Douma S. (2010).  Tumor necrosis factor antagonist-associated neutropenia: comment on the article by Hastings et al.. Arthritis Care Res (Hoboken). 62(12), 1813-5; author reply 1815.
2009
Panagopoulou, E., Triantafyllou A., Mitziori G., & Benos A. (2009).  Dyadic benefit finding after myocardial infarction: a qualitative investigation.. Heart Lung. 38(4), 292-7.
2008
Douma, S., Petidis K., Doumas M., Papaefthimiou P., Triantafyllou A., Kartali N., et al. (2008).  Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study.. Lancet. 371(9628), 1921-6.
Aslanidis, S., Pyrpasopoulou A., Douma S., & Triantafyllou A. (2008).  Tumor necrosis factor-a antagonist-induced psoriasis: yet another paradox in medicine.. Clin Rheumatol. 27(3), 377-80.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.